Skip to main content
Top

Gastric Cancer

Issue 2/2008

Content (12 Articles)

Original Article

Comparing aboral versus oral pouch with preserved duodenal passage after total gastrectomy: does the position of the gastric substitute reservoir count?

Katalin Kalmár, Zsolt Káposztás, Gábor Varga, László Cseke, András Papp, Örs Péter Horváth

Original Article

Early gastric cancer shows different associations with adipose tissue volume depending on histological type

Kensuke Otani, Joji Kitayama, Shoichi Kaisaki, Hironori Ishigami, Akio Hidemura, Mitsuhiro Fujishiro, Masao Omata, Hirokazu Nagawa

Original Article

Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer

Álvaro Díaz De Liaño, Concepción Yarnoz, Rubén Aguilar, Cristina Artieda, Héctor Ortiz

Original Article

Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer

Masao Izawa, Masashi Inoue, Mitsuhiko Osaki, Hisao Ito, Tasuku Harada, Naoki Terakawa, Masahide Ikeguchi

Original Article

Validation of staging systems for gastric cancer

Keishi Yamashita, Shinichi Sakuramoto, Shiroh Kikuchi, Natsuya Katada, Nobuyuki Kobayashi, Masahiko Watanabe

Case Report

Multiple and metachronous esophageal intramural metastases from a gastric adenocarcinoma

Osamu Ikeda, Yasushi Toh, Yoshiro Aoki, Norifumi Harimoto, Jyunya Taomoto, Takaaki Masuda, Takefumi Ohga, Eisuke Adachi, Yoshihisa Sakaguchi, Takeshi Okamura, Minako Hirahashi, Kenichi Nishiyama, Hideo Baba

Case Report

Multiple gastric carcinoids associated with parietal cell hyperplasia: intraoperative detection with a radiolabeled somatostatin analog

Yoshinori Hosoya, Kiichi Satoh, Mitsugu Hironaka, Mitsuhiro Nokubi, Kentaro Kurashina, Chiaki Shibayama, Hideharu Sugimoto, Kentaro Sugano, Hideo Nagai, Yoshikazu Yasuda

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine